Michael Monaghan

Dr. Michael Monaghan


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Biomaterials
Verified
Journal Article
Open access
Biraja DashBiraja Dash
Biraja Dash
GRGildas Réthoré
Gildas Réthoré
MMMichael Monaghan
Michael Monaghan
KFKathleen Fitzgerald
Kathleen Fitzgerald
WGWilliam M. Gallagher
William M. Gallagher
Abhay PanditAbhay Pandit
Abhay Pandit
Polymeric hollow spheres can be tailored as efficient carriers of various therapeutic molecules due to their tunable properties. However, the entry of these synthetic vehicles into cells, their cell viability and blood compatibility depend on their physical and chemical properties e.g. size, surface charge. Herein, we report the effect of size and surface charge on cell viability and cellular internalization behaviour and their effect on various blood components using chitosan/polyglutamic acid hollow spheres as a model system. Negatively charged chitosan/polyglutamic acid hollow spheres of various sizes 100, 300, 500 and 1000 nm were fabricated using a template based method and covalently surface modified using linear polyethylene glycol and methoxyethanol amine to create a gradient of surface charge from negative to neutrally charged spheres respectively. The results here suggest that both size and surface charge have a significant influence on the sphere's behaviour, most prominently on haemolysis, platelet activation, plasma recalcification time, cell viability and internalization over time. Additionally, cellular internalization behaviour and viability was found to vary with different cell types. These results are in agreement with those of inorganic spheres and liposomes, and can serve as guidelines for tailoring polymeric solid spheres for specific desired applications in biological and pharmaceutical fields, including the design of nanometer to submicron-sized delivery vehicles.

15 October 2019 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
MSMatteo Solazzo
Matteo Solazzo
Fergal O'BrienFergal O'Brien
Fergal O'Brien
VNValeria Nicolosi
Valeria Nicolosi
MMMichael Monaghan
Michael Monaghan
The human heart possesses minimal regenerative potential, which can often lead to chronic heart failure following myocardial infarction. Despite the successes of assistive support devices and pharmacological therapies, only a whole heart transplantation can sufficiently address heart failure. Engineered scaffolds, implantable patches, and injectable hydrogels are among the most promising solutions to restore cardiac function and coax regeneration; however, current biomaterials have yet to achieve ideal tissue regeneration and adequate integration due a mismatch of material physicochemical properties. Conductive fillers such as graphene, carbon nanotubes, metallic nanoparticles, and MXenes and conjugated polymers such as polyaniline, polypyrrole, and poly(3,4-ethylendioxythiophene) can possibly achieve optimal electrical conductivities for cardiac applications with appropriate suitability for tissue engineering approaches. Many studies have focused on the use of these materials in multiple fields, with promising effects on the regeneration of electrically active biological tissues such as orthopedic, neural, and cardiac tissue. In this review, we critically discuss the role of heart electrophysiology and the rationale toward the use of electroconductive biomaterials for cardiac tissue engineering. We present the emerging applications of these smart materials to create supportive platforms and discuss the crucial role that electrical stimulation has been shown to exert in maturation of cardiac progenitor cells.

12 February 2020 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
DODinorath Olvera
Dinorath Olvera
MMMina Sohrabi Molina
Mina Sohrabi Molina
GHGillian Hendy
Gillian Hendy
MMMichael Monaghan
Michael Monaghan

9 June 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
CLChristian Lotz
Christian Lotz
FSFreia F. Schmid
Freia F. Schmid
EOEva Oechsle
Eva Oechsle
MMMichael Monaghan
Michael Monaghan
HWHeike Walles
Heike Walles
FGFlorian Groeber-Becker
Florian Groeber-Becker

1 March 2021 in Advanced Drug Delivery Reviews
Verified
Journal Article
Open access
DODinorath Olvera
Dinorath Olvera
MMMichael Monaghan
Michael Monaghan
Electroactive materials are employed at the interface of biology and electronics due to their advantageous intrinsic properties as soft organic electronics. We examine the most recent literature of electroactive material-based biosensors and their emerging role as theranostic devices for the delivery of therapeutic agents. We consider electroactive materials through the lens of smart drug delivery systems as materials that enable the release of therapeutic cargo in response to specific physiological and external stimuli and discuss the way these mechanisms are integrated into medical devices with examples of the latest advances. Studies that harness features unique to conductive polymers are emphasized; lastly, we highlight new perspectives and future research direction for this emerging technology and the challenges that remain to overcome.

31 July 2019 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
SOSinead A. O'ROurke
Sinead A. O'ROurke
ADAisling Dunne
Aisling Dunne
MMMichael Monaghan
Michael Monaghan
Myocardial infarction is the most common form of acute cardiac injury attributing to heart failure. While there have been significant advances in current therapies, mortality and morbidity remain high. Emphasis on inflammation and extracellular matrix remodeling as key pathological factors has brought to light new potential therapeutic targets including macrophages which are central players in the inflammatory response following myocardial infarction. Blood derived and tissue resident macrophages exhibit both a pro- and anti-inflammatory phenotype, essential for removing injured tissue and facilitating repair, respectively. Sustained activation of pro-inflammatory macrophages evokes extensive remodeling of cardiac tissue through secretion of matrix proteases and activation of myofibroblasts. As the heart continues to employ methods of remodeling and repair, a destructive cycle prevails ultimately leading to deterioration of cardiac function and heart failure. This review summarizes not only the traditionally accepted role of macrophages in the heart but also recent advances that have deepened our understanding and appreciation of this dynamic cell. We discuss the role of macrophages in normal and maladaptive matrix remodeling, as well as studies to date which have aimed to target the inflammatory response in combatting excessive matrix deposition and subsequent heart failure.